Eisai, Biogen receives U.S. FDA approval for Alzheimer’s drug, applies for full approval January 7, 2023
Congressional report: U.S. FDA broke own protocols in approving Biogen Alzheimer’s drug December 30, 2022December 30, 2022
Positive Moderna, Merck cancer vaccine data advances mRNA promise, shares rise December 13, 2022December 13, 2022